Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn’s Disease Likely to Achieve Endoscopic and Biochemical Remission von Hanžel, Jurij, Zdovc, Jurij, Kurent, Tina, Sever, Nejc, Javornik, Katarina, Tuta, Katja, Koželj, Matic, Smrekar, Nataša, Novak, Gregor, Štabuc, Borut, Dreesen, Erwin, Thomas, Debby, Vovk, Tomaž, Grabnar, Iztok, Drobne, David

Volltext

Remission Is Maintained after Switch from Dose-Optimised Intravenous Treatment to Subcutaneous Treatment with Vedolizumab in Inflammatory Bowel Disease von Pintar, Špela, Hanžel, Jurij, Drobne, David, Koželj, Matic, Kurent, Tina, Smrekar, Nataša, Novak, Gregor

Volltext

Optimised infliximab monotherapy is as effective as optimised combination therapy, but is associated with higher drug consumption in inflammatory bowel disease von Drobne, David, Kurent, Tina, Golob, Saša, Švegl, Polona, Rajar, Polona, Hanžel, Jurij, Koželj, Matic, Novak, Gregor, Smrekar, Nataša, Ferkolj, Ivan, Štabuc, Borut

Volltext

IgA Nephropathy in a Patient Treated with Adalimumab von Mertelj, Tonja, Smrekar, Nataša, Kojc, Nika, Lindič, Jelka, Kovač, Damjan

Volltext

Insights into treatment of complex Crohn's perianal fistulas von Norčič, Gregor, Smrekar, Nataša, Marković, Srđan, Barišić, Goran, Kiudelis, Gediminas, Paužas, Henrikas, Molnár, Tamás, Szijarto, Attila, Šerclová, Zuzana, Roblek, Tina, Uršič, Viktor, White, Ian

Volltext

Comparison of radon doses based on different radon monitoring approaches von Vaupotič, Janja, Smrekar, Nataša, Žunić, Zora S.

Volltext

Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease von Hanžel, Jurij, Sever, Nejc, Ferkolj, Ivan, Štabuc, Borut, Smrekar, Nataša, Kurent, Tina, Koželj, Matic, Novak, Gregor, Compernolle, Griet, Tops, Sophie, Gils, Ann, Drobne, David

Volltext

Ustekinumab Dosing Individualization in Crohn’s Disease Guided by a Population Pharmacokinetic–Pharmacodynamic Model von Aguiar Zdovc, Jurij, Hanžel, Jurij, Kurent, Tina, Sever, Nejc, Koželj, Matic, Smrekar, Nataša, Novak, Gregor, Štabuc, Borut, Dreesen, Erwin, Thomas, Debby, Vovk, Tomaž, Ostanek, Barbara, Drobne, David, Grabnar, Iztok

Volltext

Dendritic cell profiles in the inflamed colonic mucosa predict the responses to tumor necrosis factor alpha inhibitors in inflammatory bowel disease von Smrekar, Natasa, Drobne, David, Smid, Lojze M., Ferkolj, Ivan, Stabuc, Borut, Ihan, Alojz, Kopitar, Andreja Natasa

Volltext

Ustekinumab Dosing Individualization in Crohn's Disease Guided by a Population Pharmacokinetic-Pharmacodynamic Model von Aguiar Zdovc, Jurij, Hanžel, Jurij, Kurent, Tina, Sever, Nejc, Koželj, Matic, Smrekar, Nataša, Novak, Gregor, Štabuc, Borut, Dreesen, Erwin, Thomas, Debby, Vovk, Tomaž, Ostanek, Barbara, Drobne, David, Grabnar, Iztok

Volltext

Mo1836 - Vedolizumab Trough Levels at Week 6 Predict Endoscopic and Clinical Remission in Inflammatory Bowel Disease von Hanzel, Jurij, Sever, Nejc, Ferkolj, Ivan, Stabuc, Borut, Smrekar, Natasa, Kozelj, Matic, Novak, Gregor, Gils, Ann, Drobne, David

Volltext

Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label von Stefanovic, Sebastian, Detrez, Iris, Compernolle, Griet, Brouwers, Els, Sever, Nejc, Stabuc, Borut, Smrekar, Natasa, Kurent, Tina, Novak, Gregor, Kozelj, Matic, Ferrante, Marc, Gils, Ann, Drobne, David

Volltext

Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn's Disease Likely to Achieve Endoscopic and Biochemical Remission von Hanzel, Jurij, Zdovc, Jurij, Kurent, Tina, Sever, Nejc, Javornik, Katarina, Tuta, Katja, Kozelj, Matic, Smrekar, Natasa, Novak, Gregor, Stabuc, Borut, Dreesen, Erwin, Thomas, Debby, Vovk, Tomaz, Grabnar, Iztok, Drobne, David

Volltext

Slovenska priporočila za obravnavo odraslih bolnikov s kronično odpovedjo prebavil von Nada Rotovnik Kozjek, Tajda Košir Božič, Katja Kogovšek, Borut Štabuc, Laura Petrica, Karla Berlec, Nataša Ravnjak Puzič, Erik Brecelj, Aleš Tomažič, Sanela Banovič, Rada Franko, Milena Blaž Kovač, Janez Breznik, Davorin Ćeranić, David Drobne, Mojca Gašperin, Tomaž Jurca, Maja Ebert Moltara, Rado Janša, Marjana Turk Jerovšek, Taja Jordan, Tina Kamhi Trop, Primož Karner, Milena Kerin, Neža Majdič, Denis Mlakar Mastnak, Andreja Ocepek, Tadeja Pintar, Stojan Potrč, Nataša Smrekar, Monika Sonc, Maja Šeruga, Petra Tavčar, Igor Virant

Volltext

Sa1980 High Infliximab Trough Levels Are Associated With Better Control of Inflammation in IBD von Drobne, David, Kurent, Tina, Rajar, Polona, Slak, Mateja, Kozelj, Matic, Novak, Gregor, Smrekar, Natasa, Plut, Samo, Smid, Alojz, Osredkar, Josko, Stabuc, Borut, Ferkolj, Ivan

Volltext

Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease von Hanzel, Jurij, Sever, Nejc, Ferkolj, Ivan, Stabuc, Borut, Smrekar, Natasa, Kurent, Tina, Kozelj, Matic, Novak, Gregor, Compernolle, Griet, Tops, Sophie, Gils, Ann, Drobne, David

Volltext

IgA Nephropathy in a Patient Treated with Adalimumab von Mertelj, Tonja, Smrekar, Nataša, Kojc, Nika, Lindič, Jelka, Kovač, Damjan

Volltext

Ustekinumab Dosing Individualization in Crohn's Disease Guided by a Population Pharmacokinetic-Pharmacodynamic Model von Zdovc, Jurij Aguiar, Hanzel, Jurij, Kurent, Tina, Sever, Nejc, Kozelj, Matic, Smrekar, Natasa, Novak, Gregor, Stabuc, Borut, Dreesen, Erwin, Thomas, Debby, Vovk, Tomaz, Ostanek, Barbara, Drobne, David, Grabnar, Iztok

Volltext bestellen

Success and safety of high infliximab trough levels in inflammatory bowel disease von Drobne, David, Kurent, Tina, Sasa Golob, Svegl, Polona, Rajar, Polona, Terzic, Sara, Kozelj, Matic, Novak, Gregor, Natasa Smrekar, Plut, Samo, Sever, Nejc, Strnisa, Luka, Hanzel, Jurij, Brecelj, Jernej, Urlep, Darja, Josko Osredkar, Matjaz Homan, Orel, Rok, Stabuc, Borut, Ferkolj, Ivan, Smid, Alojz

Volltext bestellen

Genska terapija v onkologiji, prvi razvojni koraki v Sloveniji von Maja Čemažar, Tanja Jesenko, Maša Bošnjak, Boštjan Markelc, Urška Kamenšek, Simona Kranjc Brezar, Špela Kos, Urša Lampreht Tratar, Katarina Žnidar, Andrej Renčelj, Urška Matkovič, Teja Valant, Kristina Levpušček, Živa Modic, Tilen Komel, Tim Božič, Urša Kešar, Barbara Starešinič, Katja Uršič Valentinuzzi, Monika Savarin, Primož Strojan, Gorana Gašljević, Maja Ota, Aleš Grošelj, Črt Jamšek, Rosana Hudej, Matjaž Peterka, Frenk Smrekar, Barbara Hubad, Marjan Hosta, Jaka Kužnik, Lojze Hosta, Damijan Miklavčič, Matej Reberšek, Aleksandra Cvetkoska, Anja Zajc, Janja Dermol-Černe, Nataša Tozon, Nina Milevoj, Alenka Nemec Svete, Gregor Serša

Volltext